A Case of Stress-Induced Cardiomyopathy After Ketamine Infusion.
Zach Hart, Thomas Anderson, Hanna Fanous, Sotiria Liori, Spencer Carter
Cureus May 1, 2024 DOI: 10.7759/cureus.59709 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 64-year-old female with hypothyroidism and isolated parotid sarcoidosis |
| Intervention | Ketamine infusion |
| Topics | Esketamine Ketamine |
| Keywords | Cardiac Imaging-MRI Catecholamine-induced myocardial toxicity Iv ketamine Stress induced cardiomyopathy Ketamine infusion Ketamine treatment Takotsubo syndrome |
| Citations | 2 |
| Key findings | Ketamine infusion may have precipitated stress-induced cardiomyopathy in a patient without obstructive coronary disease. |
Abstract
We report the case of a 64-year-old female with a history of hypothyroidism and isolated parotid sarcoidosis who presented with acute-onset chest pain and dyspnea. Echocardiogram demonstrated transiently reduced ejection fraction with apical hypokinesis, without evidence of obstructive coronary lesions on angiography, compatible with stress-induced cardiomyopathy. She received a ketamine infusion as a mental health treatment shortly before the development of symptoms, suggesting that this medication may have precipitated her cardiomyopathy. In recent years, ketamine has become a popular option for treating mental health disorders, including major depressive disorder and substance use disorders. It should be used with caution in patients with known cardiovascular disease, and its cardiac effects warrant further study.
Comparable studies
Other case reports and case series on ketamine, most cited first.